Product Information
RAPAFLO 4 MG CAPSULE is a brand product labeled by Allergan, Inc., priced at $8.4459 per EA under NDC 00023614730. Its NADAC has been published 141 times since Oct 10, 2018.
The High Outlier badge above means this manufacturer's average price in the silodosin market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
4 mg/1
Manufacturer
Allergan, Inc.NDC
00023614730
Classification
Brand
Dosage Form
CAPSULE
Route
ORAL
Last Updated
5/21/2025
Active Ingredients
SILODOSINApproval Type
New Drug (NDA)
FDA Application
NDA022206On Market Since
3/23/2009
Pharmacological Classes
Price Statistics
The NADAC for RAPAFLO 4 MG CAPSULE has been published 141 times since Oct 10, 2018, and over the history we have for it it has risen 6.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $8.4459 per EA |
|---|---|
| All-time high | $8.4459 (May 13, 2026) |
| All-time low | $7.9682 (Oct 10, 2018) |
| 52-week high | $8.4459 |
| 52-week low | $8.4459 |
| Median price | $8.4459 |
| Average price | $8.3749 |
| Largest weekly change | +4.9% (Jan 9, 2019) |
| Weeks tracked | 141 |
| Tracking since | Oct 10, 2018 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the silodosin market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of RAPAFLO 4 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for RAPAFLO 4 MG CAPSULE, manufactured by Allergan, Inc., is $8.4459 per EA (NDC 00023614730), effective May 13, 2026.
How has the price of RAPAFLO 4 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for RAPAFLO 4 MG CAPSULE has risen 6.0%. It has been tracked across 141 weekly CMS publications since Oct 10, 2018.
What are the highest and lowest recorded NADAC prices for RAPAFLO 4 MG CAPSULE?
Since Oct 10, 2018, the NADAC for RAPAFLO 4 MG CAPSULE has ranged from a low of $7.9682 (Oct 10, 2018) to a high of $8.4459 (May 13, 2026), with a median of $8.4459 per EA.
Are there cheaper alternatives to RAPAFLO 4 MG CAPSULE?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of RAPAFLO 4 MG CAPSULE, so no direct lower-cost alternative is listed.
Who manufactures RAPAFLO 4 MG CAPSULE?
RAPAFLO 4 MG CAPSULE (NDC 00023614730) is labeled by Allergan, Inc., and CMS classifies it as a brand product.